Marshall Headshot.jpg

On April 11, 2018, American Committee supporters from across the country tuned in for CEO Marshall S. Levin's most recent conference call focused on “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.”

As one of the deadliest flu seasons comes to a close, Mr. Levin informed the audience that Weizmann scientists have developed a universal flu vaccine that may provide full protection from all strains of the virus. The vaccine is now in late-stage clinical trials.

He then discussed another vital breakthrough: the discovery of a molecule that appears to unlock the renewal process and enable heart muscle repair following a heart attack. This groundbreaking research holds the promise of more effective heart disease therapies.

Lastly, Mr. Levin discussed the life-changing work of the Institute's new Center for Advanced and Intelligent Materials. As an example, he reported on a revolutionary approach to stabilizing protein structures, which could be key to preventing malaria around the world. Developed by a Weizmann Institute graduate student, this computer-based method could lead to an inexpensive malaria vaccine that does not require refrigeration. 

Through these and other initiatives, the Weizmann Institute seeks to improve the quality of life of every person on the planet.

To listen to the recording of the April 11, 2018 call, we invite you to play it here.

Call Archives:

The October 10, 2017 call featured recent advances in cancer treatment and a glimpse into the world of intelligent machines.

The inaugural February 28, 2017 call focused on Alzheimer’s research and the Bench-to-Bedside Project.

Culture & Community

Spring CEO Call Focuses on Universal Flu Vaccine, Heart Repair, and Malaria

TAGS: Community, Leadership, Philanthropy, Medicine, Virus, Biology

Marshall Headshot.jpg

On April 11, 2018, American Committee supporters from across the country tuned in for CEO Marshall S. Levin's most recent conference call focused on “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.”

As one of the deadliest flu seasons comes to a close, Mr. Levin informed the audience that Weizmann scientists have developed a universal flu vaccine that may provide full protection from all strains of the virus. The vaccine is now in late-stage clinical trials.

He then discussed another vital breakthrough: the discovery of a molecule that appears to unlock the renewal process and enable heart muscle repair following a heart attack. This groundbreaking research holds the promise of more effective heart disease therapies.

Lastly, Mr. Levin discussed the life-changing work of the Institute's new Center for Advanced and Intelligent Materials. As an example, he reported on a revolutionary approach to stabilizing protein structures, which could be key to preventing malaria around the world. Developed by a Weizmann Institute graduate student, this computer-based method could lead to an inexpensive malaria vaccine that does not require refrigeration. 

Through these and other initiatives, the Weizmann Institute seeks to improve the quality of life of every person on the planet.

To listen to the recording of the April 11, 2018 call, we invite you to play it here.

Call Archives:

The October 10, 2017 call featured recent advances in cancer treatment and a glimpse into the world of intelligent machines.

The inaugural February 28, 2017 call focused on Alzheimer’s research and the Bench-to-Bedside Project.